Tumor ploidy levels correlated with prognosis of patients with pancreatic ductal adenocarcinoma, in contrast, to the absence of a prognostic effect on patient outcome regarding HER2 gene amplification or p185 (HER2) overexpression [42]. This evidence concerns the gene ERBB2 and neoplasm.